This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

The Run-Up Trade: Biodel's Insulin Trial Results

Biodel shares should move higher ahead of insulin trial results in the third quarter.

Rockwell Medical Run-Up Trade Follows Financing

One trader believes Rockwell shares will rise into clinical trial results expected in July.

Synta Is Run-Up to ASCO Lung Cancer Data

The market overreacted to the resignation of Synta's R&D chief.

Expecting Ziopharm Shares To Run Into Phase III Data At Month's End

Ziopharm is an example of a stock with clinical trial results that can be traded realtively safely.

Run-Up Trade Into Dynavax's FDA Approval Decision

Three factors that will cause Dynavax shares to gain as get closer to the approval of its Hep B vaccine.

Titan Pharma: Run-Up Trade Into March FDA Panel

I expect traders will get an opportunity to profit from increased focus on Titan through March.

A.P. Pharma Run-Up Trade Into FDA Approval Decision

Look at A.P. Pharma as a trade, not as a long-term investment, says trader Mark Messier.

Shorting Alexza Pharma On FDA's Adasuve Approval

Alexza is setting up as a classic biotech run-down stock, says trader Mark Messier.

Anacor Pharma: Run-Up Trade Into January Trial Data

Anacor will be releasing phase III results for a toenail fungus drug in January.

Hyperion Shares Poised to Run Up Ahead of FDA Decision

FDA expected to issue approval decision on orphan drug Ravicti on Jan. 23.

Page 1 of 2
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs